![Anders Gabrielsen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anders Gabrielsen is currently an Independent Director at Novakand Pharma AB since 2018.
Dr. Gabrielsen is an Associate Professor at Karolinska Institutet.
Dr. Gabrielsen is the Chief Medical Officer at Suzhou Ribo Life Science Co., Ltd. starting in 2026.
Formerly, Dr. Gabrielsen was Director-Global Medical Affairs Unit at Novartis Sverige AB from 2016 to 2018.
| Empresas | Cargo | Inicio |
|---|---|---|
| KANCERA AB | Director/Miembro de la Junta | 30/05/2018 |
| SUZHOU RIBO LIFE SCIENCE CO., LTD. | Director Técnico/Científico/I+D | - |
Karolinska Institutet
 Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| Empresas | Cargo | Fin |
|---|---|---|
Novartis Sverige AB
 Novartis Sverige AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical, ophthalmic and generic drugs | Director Técnico/Científico/I+D | 01/05/2018 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Sverige AB
Novartis Sverige AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical, ophthalmic and generic drugs | Health Technology |
Kancera AB
 Kancera AB Pharmaceuticals: MajorHealth Technology Develops drugs against inflammation and cancer | Health Technology |
Suzhou Ribo Life Science Co., Ltd.
 Suzhou Ribo Life Science Co., Ltd. Pharmaceuticals: GenericHealth Technology Develops siRNA therapeutics for liver, cardiovascular, metabolic and renal diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
